| Jiaqi Tracy Li, PAA | |
|
1001 Johnson Fy Rd Ne, Atlanta, GA 30342-1605 | |
| (404) 785-2008 | |
| (404) 785-4496 |
| Full Name | Jiaqi Tracy Li |
|---|---|
| Gender | Female |
| Speciality | Anesthesiologist Assistant |
| Location | 1001 Johnson Fy Rd Ne, Atlanta, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003289711 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | 7750 (Georgia) | Primary |
| Entity Name | Anesthesia Associates Of Gainesville, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457456485 PECOS PAC ID: 2769381771 Enrollment ID: O20040108000009 |
News Archive
Cephalon, Inc. today announced that a Risk Evaluation and Mitigation Strategy (REMS) for its antiepileptic medication GABITRIL(R) (tiagabine hydrochloride) has been approved by the U.S. Food and Drug Administration (FDA). The GABITRIL REMS consists of a Medication Guide to inform patients about the potential risks associated with the use of GABITRIL.
When doctors at the University of Iowa prepared a patient to inhale a panic-inducing dose of carbon dioxide, she was fearless. But within seconds of breathing in the mixture, she cried for help, overwhelmed by the sensation that she was suffocating.
The New Orleans Times-Picayune reports that a "health care overhaul faces a tough sell among the Louisiana delegation:" "Sen. Mary Landrieu, D-La., said the bill pending ... isn't aggressive enough in trying to curb rising health care costs. But she also said that doing nothing is not an option with so many Louisiana families and small businesses unable to afford health coverage.
Brian Kaspar, PhD, principal investigator in the Center for Gene Therapy at The Research Institute at Nationwide Children's Hospital, along with a team of Spinal Muscular Atrophy (SMA) researchers and clinicians, recently received a $250,000 grant for SMA research and clinic development from Sophia's Cure Foundation via the Pepsi Refresh Project.
› Verified 1 days ago
| Entity Name | Ambulatory Anesthesia Of North Georgia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497870562 PECOS PAC ID: 9931121332 Enrollment ID: O20051229000181 |
News Archive
Cephalon, Inc. today announced that a Risk Evaluation and Mitigation Strategy (REMS) for its antiepileptic medication GABITRIL(R) (tiagabine hydrochloride) has been approved by the U.S. Food and Drug Administration (FDA). The GABITRIL REMS consists of a Medication Guide to inform patients about the potential risks associated with the use of GABITRIL.
When doctors at the University of Iowa prepared a patient to inhale a panic-inducing dose of carbon dioxide, she was fearless. But within seconds of breathing in the mixture, she cried for help, overwhelmed by the sensation that she was suffocating.
The New Orleans Times-Picayune reports that a "health care overhaul faces a tough sell among the Louisiana delegation:" "Sen. Mary Landrieu, D-La., said the bill pending ... isn't aggressive enough in trying to curb rising health care costs. But she also said that doing nothing is not an option with so many Louisiana families and small businesses unable to afford health coverage.
Brian Kaspar, PhD, principal investigator in the Center for Gene Therapy at The Research Institute at Nationwide Children's Hospital, along with a team of Spinal Muscular Atrophy (SMA) researchers and clinicians, recently received a $250,000 grant for SMA research and clinic development from Sophia's Cure Foundation via the Pepsi Refresh Project.
› Verified 1 days ago
| Entity Name | Coastal Ambulatory Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750753786 PECOS PAC ID: 1052613023 Enrollment ID: O20160107001775 |
News Archive
Cephalon, Inc. today announced that a Risk Evaluation and Mitigation Strategy (REMS) for its antiepileptic medication GABITRIL(R) (tiagabine hydrochloride) has been approved by the U.S. Food and Drug Administration (FDA). The GABITRIL REMS consists of a Medication Guide to inform patients about the potential risks associated with the use of GABITRIL.
When doctors at the University of Iowa prepared a patient to inhale a panic-inducing dose of carbon dioxide, she was fearless. But within seconds of breathing in the mixture, she cried for help, overwhelmed by the sensation that she was suffocating.
The New Orleans Times-Picayune reports that a "health care overhaul faces a tough sell among the Louisiana delegation:" "Sen. Mary Landrieu, D-La., said the bill pending ... isn't aggressive enough in trying to curb rising health care costs. But she also said that doing nothing is not an option with so many Louisiana families and small businesses unable to afford health coverage.
Brian Kaspar, PhD, principal investigator in the Center for Gene Therapy at The Research Institute at Nationwide Children's Hospital, along with a team of Spinal Muscular Atrophy (SMA) researchers and clinicians, recently received a $250,000 grant for SMA research and clinic development from Sophia's Cure Foundation via the Pepsi Refresh Project.
› Verified 1 days ago
| Entity Name | Children's Anesthesia Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437203098 PECOS PAC ID: 5092105932 Enrollment ID: O20211208000072 |
News Archive
Cephalon, Inc. today announced that a Risk Evaluation and Mitigation Strategy (REMS) for its antiepileptic medication GABITRIL(R) (tiagabine hydrochloride) has been approved by the U.S. Food and Drug Administration (FDA). The GABITRIL REMS consists of a Medication Guide to inform patients about the potential risks associated with the use of GABITRIL.
When doctors at the University of Iowa prepared a patient to inhale a panic-inducing dose of carbon dioxide, she was fearless. But within seconds of breathing in the mixture, she cried for help, overwhelmed by the sensation that she was suffocating.
The New Orleans Times-Picayune reports that a "health care overhaul faces a tough sell among the Louisiana delegation:" "Sen. Mary Landrieu, D-La., said the bill pending ... isn't aggressive enough in trying to curb rising health care costs. But she also said that doing nothing is not an option with so many Louisiana families and small businesses unable to afford health coverage.
Brian Kaspar, PhD, principal investigator in the Center for Gene Therapy at The Research Institute at Nationwide Children's Hospital, along with a team of Spinal Muscular Atrophy (SMA) researchers and clinicians, recently received a $250,000 grant for SMA research and clinic development from Sophia's Cure Foundation via the Pepsi Refresh Project.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jiaqi Tracy Li, PAA 1001 Johnson Fy Rd Ne, Atlanta, GA 30342-1605 Ph: (404) 785-2008 | Jiaqi Tracy Li, PAA 1001 Johnson Fy Rd Ne, Atlanta, GA 30342-1605 Ph: (404) 785-2008 |
News Archive
Cephalon, Inc. today announced that a Risk Evaluation and Mitigation Strategy (REMS) for its antiepileptic medication GABITRIL(R) (tiagabine hydrochloride) has been approved by the U.S. Food and Drug Administration (FDA). The GABITRIL REMS consists of a Medication Guide to inform patients about the potential risks associated with the use of GABITRIL.
When doctors at the University of Iowa prepared a patient to inhale a panic-inducing dose of carbon dioxide, she was fearless. But within seconds of breathing in the mixture, she cried for help, overwhelmed by the sensation that she was suffocating.
The New Orleans Times-Picayune reports that a "health care overhaul faces a tough sell among the Louisiana delegation:" "Sen. Mary Landrieu, D-La., said the bill pending ... isn't aggressive enough in trying to curb rising health care costs. But she also said that doing nothing is not an option with so many Louisiana families and small businesses unable to afford health coverage.
Brian Kaspar, PhD, principal investigator in the Center for Gene Therapy at The Research Institute at Nationwide Children's Hospital, along with a team of Spinal Muscular Atrophy (SMA) researchers and clinicians, recently received a $250,000 grant for SMA research and clinic development from Sophia's Cure Foundation via the Pepsi Refresh Project.
› Verified 1 days ago
Matthew Lewis, PAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 1405 Clifton Rd Ne Fl 3, Atlanta, GA 30322 Phone: 404-785-6670 Fax: 404-785-1362 | |
Elizabeth Ikeda, Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 1365 Clifton Rd Ne, Atlanta, GA 30322 Phone: 404-778-8311 | |
Amar R Herndon, Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 1000 Johnson Ferry Rd Ne, Atlanta, GA 30342 Phone: 770-645-9181 | |
Shelley S Staton, PAAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 1000 Johnson Ferry Rd, Atlanta, GA 30342 Phone: 770-645-9181 Fax: 770-645-8455 | |
Mr. Grant Michael Mury, PAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 550 Peachtree St Ne, Atlanta, GA 30308 Phone: 404-778-3900 | |
Ashley Schade, PAAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 5665 Peachtree Dunwoody Rd, Atlanta, GA 30342 Phone: 706-543-3449 |